TY  - GEN
AU  - Lin,Hsiao-Hui
AU  - Feng,Wen-Chi
AU  - Lu,Li-Chun
AU  - Shao,Yu-Yun
AU  - Hsu,Chih-Hung
AU  - Cheng,Ann-Lii
TI  - Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma
SN  - 1872-7980
PY  - 2017///0728
KW  - Animals
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - pharmacology
KW  - Apoptosis
KW  - drug effects
KW  - Apoptosis Regulatory Proteins
KW  - metabolism
KW  - Bridged Bicyclo Compounds, Heterocyclic
KW  - Carcinoma, Hepatocellular
KW  - genetics
KW  - Cell Proliferation
KW  - Dose-Response Relationship, Drug
KW  - Gene Expression Regulation, Neoplastic
KW  - Hep G2 Cells
KW  - Humans
KW  - Liver Neoplasms
KW  - Male
KW  - Mice, Inbred BALB C
KW  - Mice, Nude
KW  - Myeloid Cell Leukemia Sequence 1 Protein
KW  - Niacinamide
KW  - analogs & derivatives
KW  - Phenylurea Compounds
KW  - Protein Kinase Inhibitors
KW  - Pyrimidinones
KW  - RNA Interference
KW  - RNAi Therapeutics
KW  - Sorafenib
KW  - Transfection
KW  - Wnt Signaling Pathway
KW  - Xenograft Model Antitumor Assays
KW  - beta Catenin
KW  - antagonists & inhibitors
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1016/j.canlet.2016.07.013
ER  -